CBIO
Crescent Biopharma, Inc. (CBIO)
NASDAQ · Healthcare
Crescent Biopharma, Inc. annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Crescent Biopharma, Inc. revenue for the quarter ending March 31, 2026 was 1.0 M.
- Crescent Biopharma, Inc. revenue for the twelve months ending March 31, 2026 was 1.2 M, a 89.14% decrease year-over-year.
- Crescent Biopharma, Inc. annual revenue for 2025 was 10.8 M, a 108340.00% increase from 2023.
- Crescent Biopharma, Inc. annual revenue for 2023 was 10000, a 86.67% decrease from 2022.
- Crescent Biopharma, Inc. annual revenue for 2022 was 75000, a 93.53% decrease from 2021.
- Crescent Biopharma, Inc. annual revenue for 2021 was 1.2 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Crescent Biopharma, Inc. Earnings — FAQ
Crescent Biopharma, Inc. (CBIO) earnings over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CBIO's earnings history?
The chart and table above show Crescent Biopharma, Inc.'s earnings by year and by quarter, including the growth rate.